Abstract
Background: Mental health problems are elevated in autistic individuals but there is limited evidence on the developmental course of problems across childhood. We compare the level and growth of anxious-depressed, behavioral and attention problems in an autistic and typically developing (TD) cohort.
Methods: Latent growth curve models were applied to repeated parent-report Child Behavior Checklist data from age 2-10 years in an inception cohort of autistic children (Pathways, N = 397; 84% boys) and a general population TD cohort (Wirral Child Health and Development Study; WCHADS; N = 884, 49% boys). Percentile plots were generated to quantify the differences between autistic and TD children.
Results: Autistic children showed elevated levels of mental health problems, but this was substantially reduced by accounting for IQ and sex differences between the autistic and TD samples. There was small differences in growth patterns; anxious-depressed problems were particularly elevated at preschool and attention problems at late childhood. Higher family income predicted lower base-level on all three dimensions, but steeper increase of anxious-depressed problems. Higher IQ predicted lower level of attention problems and faster decline over childhood. Female sex predicted higher level of anxious-depressed and faster decline in behavioral problems. Social-affect autism symptom severity predicted elevated level of attention problems. Autistic girls' problems were particularly elevated relative to their same-sex non-autistic peers.
Conclusions: Autistic children, and especially girls, show elevated mental health problems compared to TD children and there are some differences in predictors. Assessment of mental health should be integrated into clinical practice for autistic children.
Original language | English |
---|---|
Pages (from-to) | 7707-7719 |
Number of pages | 13 |
Journal | Psychological Medicine |
Volume | 53 |
Issue number | 16 |
Early online date | 29 Jun 2023 |
DOIs | |
Publication status | Published - 29 Dec 2023 |
Bibliographical note
Funding Information:The WCHADS was funded by the Medical Research Council (grant number: G0400577, G0900654; MR/L022257/1). The Pathways study was supported by: Canadian Institutes of Health Research, Fonds de Recherche du Québec, Kids Brain Health Network (formerly NeuroDevNet), Autism Speaks (US), Government of British Columbia, Alberta Innovates Health Solutions, and the Sinneave Family Foundation. AP and NW were partially supported by NIHR grant NF-SI-0617-10120 and NIHR Maudsley Biomedical Research Centre. VC is supported by CIHR. RB is supported by a King's Prize Fellowship (204823/Z/16/Z).
Funding
The authors are grateful to all participating families in WCHADS and Pathways and to the research staff who contributed to this work. The Pathways authors acknowledge the past and present members of the Pathways in ASD study team, who made equal contributions to the study. The WCHADS authors acknowledge the Wirral University Teaching Hospital NHS Foundation Trust, Wirral Community NHS Foundation Trust, Cheshire and Wirral Partnership NHS Foundation Trust who supported the recruitment into the study in pregnancy and to the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The Pathways authors acknowledge support from the Azrieli Centre for Autism Research (ACAR), The Canadian Institutes of Health Research, Fonds de Recherche du Québec, Kids Brain Health Network (formerly NeuroDevNet), Autism Speaks (US), Government of British Columbia, Alberta Innovates Health Solutions, and the Sinneave Family Foundation. The WCHADS was funded by the Medical Research Council (grant number: G0400577, G0900654; MR/L022257/1). The Pathways study was supported by: Canadian Institutes of Health Research, Fonds de Recherche du Québec, Kids Brain Health Network (formerly NeuroDevNet), Autism Speaks (US), Government of British Columbia, Alberta Innovates Health Solutions, and the Sinneave Family Foundation. AP and NW were partially supported by NIHR grant NF-SI-0617-10120 and NIHR Maudsley Biomedical Research Centre. VC is supported by CIHR. RB is supported by a King's Prize Fellowship (204823/Z/16/Z).
Keywords
- attention problems
- Autism
- behavioral problems
- emotional problems
- longitudinal
- trajectories
ASJC Scopus subject areas
- Applied Psychology
- Psychiatry and Mental health